[Clinical evaluation of a new formulation of an antigastritic preparation].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001729:Bismuth / Q000627:therapeutic use; D002119:Calcium Carbonate / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D005756:Gastritis / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006035:Glycyrrhiza; D006801:Humans; D008277:Magnesium Oxide / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010946:Plants, Medicinal; D010947:Plants, Toxic; D031955:Rhamnus
D004338:Drug Combinations; D005765:Gastrointestinal Agents; D008277:Magnesium Oxide; D002119:Calcium Carbonate; D001729:Bismuth
Valutazione clinica di una nuova formulazione di un preparato antigastritico